Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rhodopsin Antikörper (C-Term)

RHO Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN350798
  • Target Alle Rhodopsin (RHO) Antikörper anzeigen
    Rhodopsin (RHO)
    Bindungsspezifität
    • 7
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reaktivität
    • 38
    • 17
    • 16
    • 15
    • 10
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 38
    • 26
    • 2
    • 1
    • 1
    Kaninchen
    Klonalität
    • 34
    • 33
    • 1
    Polyklonal
    Konjugat
    • 27
    • 6
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Dieser Rhodopsin Antikörper ist unkonjugiert
    Applikation
    • 51
    • 42
    • 34
    • 25
    • 14
    • 12
    • 10
    • 8
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC)
    Spezifität
    Specific for Rhodopsin.
    Immunogen
    A synthetic peptide from c-terminal region of human Rhodopsin (OPSD, Opsin-2) conjugated to an immunogenic carrier protein was used as the antigen. The antigen is homologous in mouse and rat.
    Isotyp
    IgG
    Top Product
    Discover our top product RHO Primärantikörper
  • Applikationshinweise
    A concentration of 10-50 µg/ml is recommended.
    The optimal concentration should be determined by the end user.
    Not yet tested in other applications.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Reconstitute in 500 µL of sterile water. Centrifuge to remove any insoluble material.
    Handhabung
    Avoid freeze and thaw cycles.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.
    Haltbarkeit
    12 months
  • Target
    Rhodopsin (RHO)
    Andere Bezeichnung
    Rhodopsin (RHO Produkte)
    Synonyme
    CSNBAD1 antikoerper, OPN2 antikoerper, RP4 antikoerper, RH1 antikoerper, Rh antikoerper, fi06d11 antikoerper, wu:fi06d11 antikoerper, zfo2 antikoerper, zfrho antikoerper, Noerg1 antikoerper, Opn2 antikoerper, Ops antikoerper, opn2 antikoerper, rh1 antikoerper, rp4 antikoerper, xrho antikoerper, PIGRHO1 antikoerper, ops antikoerper, RDP1 antikoerper, RHO antikoerper, rhodopsin antikoerper, rhodopsin L homeolog antikoerper, RHO antikoerper, Rho antikoerper, rho antikoerper, rho.L antikoerper
    Substanzklasse
    Chemical
    Hintergrund
    Function: Photoreceptor required for image-forming vision at low light intensity. Required for photoreceptor cell viability after birth. Light-induced isomerization of 11-cis to all-trans retinal triggers a conformational change leading to G-protein activation and release of all-trans retinal. BIOPHYSICOCHEMICAL PROPERTIES: Absorption: Abs(max)=495 nm,
    Subcellular location: Membrane, Multi-pass membrane protein.
    Tissue specificity: Rod shaped photoreceptor cells which mediates vision in dim light. PTM: Phosphorylated on some or all of the serine and threonine residues present in the C-terminal region. DISEASE: Defects in RHO are the cause of retinitis pigmentosa type 4 (RP4). RP leads to degeneration of retinal photoreceptor cells. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP4 inheritance is autosomal dominant. DISEASE: Defects in RHO are a cause of retinitis pigmentosa autosomal recessive (ARRP). DISEASE: Defects in RHO are a cause of autosomal dominant congenital stationary night blindness 1 (CSNBAD1), also known as rhodopsin-related congenital stationary night blindness. Congenital stationary night blindness is a nonprogressive retinal disorder characterized by impaired night vision and ocular symptoms such as myopia, hyperopia, nystagmus and reduced visual acuity. Also known as: Rhodopsin, opsin-2, RHO, OPN2, RP4, MGC138309, MGC138311.
    Pathways
    WNT Signalweg, Sensory Perception of Sound, Regulation of G-Protein Coupled Receptor Protein Signaling, Phototransduction
Sie sind hier:
Kundenservice